Serum hyaluronan levels in oral cancer patients

Chinese Medical Journal

Volumn 121, Issue 4, 2008, Pages 327-330

  Xing, Ru Dong ^a   Chang, Shi Min ^b   Li, Jian Hua ^a   Li, Hua ^a   Han, Xheng Xue ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Hyaluronan; Oral cancer; Serum

Indexed keywords

ANTINEOPLASTIC AGENT; HYALURONIC ACID;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; FACE TUMOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE; VENOUS BLOOD; BLOOD; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY;

AGED; HUMANS; HYALURONIC ACID; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING;

EID: 41649107836     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200802020-00009     Document Type: Article

References (25)

1. Knudson W, Biswas C, Li XQ, Nemec RE, Toole BP. The role and regulation of tumor-associated hyaluronan. Ciba Found Symp 1989; 143: 150-159.
2. Toole BP. Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol 1990; 2: 839-844.
3. Laurent TC, Fraser RE. Hyaluronan. FASEB 1992; 6: 2397-2404.
4. Turley EA, Torrance J. Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exp Cell Res 1985; 161: 17-28.
5. Toole BP. Glycosaminoglycans in morphogenesis. Cell Biology of Extracellular Matrix. In: Hay ED, ed. New York: Plenum Press; 1981: 259-294.
6. Zhang L, Underhill CB, Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 1995; 55: 428-433.
7. Kojima J, Nakamura N, Kanatani M, Omori K. The glycosaminoglycans in human hepatic cancer. Cancer Res 1975; 35: 542-547.
8. Roboz J, Greaves J, Silides D, Chahinian AP, Holland JF. Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma. Cancer Res 1985; 45: 1850-1854.
9. Horai T, Nakamura N, Tateishi R, Hattori S. Glycosaminoglycans in human lung cancer. Cancer 1981; 48: 2016-2021.
10. Fries H, Elsasser HP, Mahlbacher V, Neumann K, Kern HF. Localization of hyaluronate (HA) in primary tumors and nude mouse xenografts of human pancreatic carcinomas using a biotinylated HA-binding protein. Virchows Archiv 1994; 424: 7-12.
11. Dahl IM, Turesson I, Holmberg E, Lilja K. Serum hyaluronan in patients with multiple myeloma: correlation with survival and Ig concentralion. Blood 1999; 93: 4144-4148.
12. Delpech B, Chevallier B, Reinhardt N, Julien JP, Duval C, Maingonnat C, et al. Serum hyaluronan (hyaluronic acid) in breast cancer patients. Int J Cancer 1990; 15; 46: 388-390.
13. Hautmann SH, Schroeder GL, Civantos F, Duncan RC, Gnann R, Friedrich MG, et al. Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers. Urologe A 2001; 40: 121-126.
14. Hiltunen EL, Anttila M, Kultti A, Ropponen K, Penttinen J, Yliskoski M, et al. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res 2002; 62: 6410-6413.
15. Hotta T, Taniguchi K, Kobayashi Y, Johata K, Sahara M, Naka T, et al. Chemotherapy and serum hyaluronic acid levels in malignant peritoneal mesothelioma. Hepatogastroenterology 2004; 51: 1073-1083.
16. Burchardt ER, Hein R, Bosserhoff AK. Laminin, hyaluronan, tenascin-C and-type VI collagen levels in sera from patients with malignant melanoma. Clin Exp Dermatol 2003; 28: 515-520.
17. Fuhrman C, Duche JC, Chouaid C, Abd Alsamad I, Atassi K, Monnet I, et al. Use of tumor markers for differential diagnosis of mesothelioma and, secondary pleural malignancies. Clin Biochem 2000; 33: 405-410.
18. Engstrom-laurent A, Loof L, Nyberg A, Schroder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985; 5: 638-642.
19. Engstrom-laurent A, Hallgren R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985; 44: 83-88.
20. Kumar S, West DC, Ponting JM, Gattamaneni HR. Sera of children with renal tumours contain tow-Molecular-mass hyaluronic acid. Int J Cancer 1989, 44: 445-448.
21. Makita A, Shimojo H. Polysaccharides of SV 40-transformed green monkey kidney cells. Biochim Biophys Acta 1973; 304: 571-574.
22. Knudson W, Biswas C, Toole BP. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci U S A 1984; 81: 6767-6771.
23. Thylen A, Wallin J, Martensson G. Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma. Cancer 1999; 86: 2000-2005.
24. Hasselbalch H, Hovgaard D, Nissen N, Junker P. Serum hyaluronan is increased in malignant lymphoma. Am J Hematol 1995; 50: 231-233.
25. Delpech B, Girard N, Bertrand P, Courel MN, Chauzy C, Delpech A. Hyaluronan: fundamental principles and applications in cancer. J Intern Med 1997; 242: 41-48.